Your browser doesn't support javascript.
loading
MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas.
Illmer, Julia; Zauner, Roland; Piñón Hofbauer, Josefina; Wimmer, Monika; Gruner, Stefanie; Ablinger, Michael; Bischof, Johannes; Dorfer, Sonja; Hainzl, Stefan; Tober, Vanessa; Bergson, Shir; Sarig, Ofer; Samuelov, Liat; Guttmann-Gruber, Christina; Shalom-Feuerstein, Ruby; Sprecher, Eli; Koller, Ulrich; Laimer, Martin; Bauer, Johann W; Wally, Verena.
Afiliación
  • Illmer J; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Austria.
  • Zauner R; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Austria.
  • Piñón Hofbauer J; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Austria.
  • Wimmer M; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Austria.
  • Gruner S; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Austria.
  • Ablinger M; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Austria.
  • Bischof J; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Austria.
  • Dorfer S; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Austria.
  • Hainzl S; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Austria.
  • Tober V; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Austria.
  • Bergson S; Division of Dermatology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
  • Sarig O; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Samuelov L; Division of Dermatology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
  • Guttmann-Gruber C; Division of Dermatology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
  • Shalom-Feuerstein R; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Sprecher E; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Austria.
  • Koller U; Department of Genetics and Developmental Biology, The Rappaport Faculty of Medicine and Research Institute, Technion Israel Institute of Technology, Haifa, Israel.
  • Laimer M; Division of Dermatology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
  • Bauer JW; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Wally V; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Austria.
Br J Dermatol ; 190(1): 80-93, 2023 Dec 20.
Article en En | MEDLINE | ID: mdl-37681509
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Carcinoma de Células Escamosas / Epidermólisis Ampollosa Distrófica / MicroARNs / Transición Epitelial-Mesenquimal Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Br J Dermatol Año: 2023 Tipo del documento: Article País de afiliación: Austria
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Carcinoma de Células Escamosas / Epidermólisis Ampollosa Distrófica / MicroARNs / Transición Epitelial-Mesenquimal Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Br J Dermatol Año: 2023 Tipo del documento: Article País de afiliación: Austria